- Home
- XMTR vs LENZ Comparison
XMTR vs LENZ Comparison
Compare XMTR & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XMTR
- LENZ
- Stock Information
- Founded
- XMTR 2013
- LENZ 2019
- Country
- XMTR United States
- LENZ United States
- Employees
- XMTR N/A
- LENZ N/A
- Industry
- XMTR Industrial Machinery/Components
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- XMTR Technology
- LENZ Health Care
- Exchange
- XMTR Nasdaq
- LENZ Nasdaq
- Market Cap
- XMTR 1.0B
- LENZ 886.2M
- IPO Year
- XMTR 2021
- LENZ 2021
- Fundamental
- Price
- XMTR $40.29
- LENZ $32.54
- Analyst Decision
- XMTR Buy
- LENZ Strong Buy
- Analyst Count
- XMTR 8
- LENZ 6
- Target Price
- XMTR $32.00
- LENZ $35.40
- AVG Volume (30 Days)
- XMTR 484.1K
- LENZ 105.1K
- Earning Date
- XMTR 11-05-2024
- LENZ 11-06-2024
- Dividend Yield
- XMTR N/A
- LENZ N/A
- EPS Growth
- XMTR N/A
- LENZ N/A
- EPS
- XMTR N/A
- LENZ N/A
- Revenue
- XMTR $525,128,000.00
- LENZ N/A
- Revenue This Year
- XMTR $19.60
- LENZ N/A
- Revenue Next Year
- XMTR $19.06
- LENZ N/A
- P/E Ratio
- XMTR N/A
- LENZ N/A
- Revenue Growth
- XMTR 21.19
- LENZ N/A
- 52 Week Low
- XMTR $11.08
- LENZ $2.23
- 52 Week High
- XMTR $38.74
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- XMTR 85.42
- LENZ 49.37
- Support Level
- XMTR $33.15
- LENZ $30.56
- Resistance Level
- XMTR $35.34
- LENZ $34.73
- Average True Range (ATR)
- XMTR 1.85
- LENZ 2.21
- MACD
- XMTR 0.40
- LENZ -0.66
- Stochastic Oscillator
- XMTR 92.16
- LENZ 32.86
About XMTR Xometry Inc.
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of the revenue is earned from the U.S. segment.
About LENZ LENZ Therapeutics Inc. Common Stock
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.